International Stem Cell (ISCO)
OTHER OTC:ISCO
Total Valuation
International Stem Cell has a market cap or net worth of $1.36M. The enterprise value is $760.75K.
Market Cap$1.36M
Enterprise Value$760.75K
Share Statistics
International Stem Cell has 8,004,389 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,004,389
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
International Stem Cell’s return on equity (ROE) is -1.74 and return on invested capital (ROIC) is -42.18%.
Return on Equity (ROE)-1.74
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-42.18%
Return on Capital Employed (ROCE)-1.11
Revenue Per Employee284.38K
Profits Per Employee-13.06K
Employee Count32
Asset Turnover1.89
Inventory Turnover2.66
Valuation Ratios
The current PE Ratio of International Stem Cell is ―. International Stem Cell’s PEG ratio is -0.03.
PE Ratio―
PS Ratio0.12
PB Ratio4.67
Price to Fair Value4.67
Price to FCF-32.02
Price to Operating Cash Flow170.09
PEG Ratio-0.03
Income Statement
In the last 12 months, International Stem Cell had revenue of 9.10M and earned -418.00K in profits. Earnings per share was -0.05.
Revenue9.10M
Gross Profit5.07M
Operating Income-267.00K
Pretax Income-418.00K
Net Income-418.00K
EBITDA-267.00K
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was 8.00K and capital expenditures -43.00K, giving a free cash flow of -35.00K billion.
Operating Cash Flow8.00K
Free Cash Flow-35.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
International Stem Cell pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.16
52-Week Price Change41.67%
50-Day Moving Average0.16
200-Day Moving Average0.15
Relative Strength Index (RSI)58.10
Average Volume (3m)2.04K
Important Dates
International Stem Cell upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
International Stem Cell as a current ratio of 0.74, with Debt / Equity ratio of 163.75%
Current Ratio0.74
Quick Ratio0.41
Debt to Market Cap0.35
Net Debt to EBITDA2.25
Interest Coverage Ratio44.50
Taxes
In the past 12 months, International Stem Cell has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
International Stem Cell EV to EBITDA ratio is -1.95, with an EV/FCF ratio of -14.87.
EV to Sales0.06
EV to EBITDA-1.95
EV to Free Cash Flow-14.87
EV to Operating Cash Flow65.08
Balance Sheet
International Stem Cell has $993.00K in cash and marketable securities with $393.00K in debt, giving a net cash position of $600.00K billion.
Cash & Marketable Securities$993.00K
Total Debt$393.00K
Net Cash$600.00K
Net Cash Per Share$0.07
Tangible Book Value Per Share-$0.05
Margins
Gross margin is 55.68%, with operating margin of -2.93%, and net profit margin of -4.59%.
Gross Margin55.68%
Operating Margin-2.93%
Pretax Margin-4.59%
Net Profit Margin-4.59%
EBITDA Margin-2.93%
EBIT Margin0.00%
Analyst Forecast
The average price target for International Stem Cell is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast10.12%
EPS Growth Forecast79.74%